Acquisition of brilliant violet 650 anti-human CD197 (CCR7), G043H7.
Ended Awarded
- Contract number
- HHSN27200028
- Awardee
-
Biolegend, Inc. UEI WVJUG294HEM6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,820
Award facts
- Contract value 100% obligated
- $17,820.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN27200028?
HHSN27200028 was awarded to Biolegend, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 11, 2017.
How much is contract HHSN27200028 worth?
The government has obligated $17,820 on HHSN27200028.
Is contract HHSN27200028 an order under another contract?
Yes. HHSN27200028 is a BPA call under HHSN263200800029B, a blanket purchase agreement.
Was contract HHSN27200028 competed?
The extent of competition for HHSN27200028 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award